TNGXTango Therapeutics, Inc.

Nasdaq tangotx.com


$ 7.34 $ -0.43 (-5.54 %)    

Thursday, 25-Apr-2024 15:59:55 EDT
QQQ $ 430.17 $ -2.06 (-0.48 %)
DIA $ 380.88 $ -3.52 (-0.92 %)
SPY $ 507.81 $ -1.92 (-0.38 %)
TLT $ 87.78 $ -0.62 (-0.7 %)
GLD $ 215.92 $ 1.28 (0.6 %)
$ 7.33
$ 7.42
$ 0.00 x 0
$ 0.00 x 0
$ 7.20 - $ 7.43
$ 2.47 - $ 13.03
447,982
na
693.22M
$ 0.78
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-18-2024 12-31-2023 10-K
2 11-08-2023 09-30-2023 10-Q
3 08-07-2023 06-30-2023 10-Q
4 05-09-2023 03-31-2023 10-Q
5 03-27-2023 12-31-2022 10-K
6 11-10-2022 09-30-2022 10-Q
7 08-10-2022 06-30-2022 10-Q
8 05-11-2022 03-31-2022 10-Q
9 03-28-2022 12-31-2021 10-K
10 11-09-2021 09-30-2021 10-Q
11 08-09-2021 06-30-2021 10-Q
12 05-14-2021 03-31-2021 10-Q
13 03-31-2021 12-31-2020 10-K
14 11-13-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cantor-fitzgerald-initiates-coverage-on-tango-therapeutics-with-overweight-rating

Cantor Fitzgerald analyst Eric Schmidt initiates coverage on Tango Therapeutics (NASDAQ:TNGX) with a Overweight rating.

 hc-wainwright--co-maintains-buy-on-tango-therapeutics-raises-price-target-to-17

HC Wainwright & Co. analyst Robert Burns maintains Tango Therapeutics (NASDAQ:TNGX) with a Buy and raises the price targ...

 tango-therapeutics-q4-gaap-eps-032-misses-028-estimate-sales-543m-miss-824m-estimate

Tango Therapeutics (NASDAQ:TNGX) reported quarterly losses of $(0.32) per share which missed the analyst consensus estimate of ...

 piper-sandler-initiates-coverage-on-tango-therapeutics-with-overweight-rating-announces-price-target-of-18

Piper Sandler analyst Joseph Catanzaro initiates coverage on Tango Therapeutics (NASDAQ:TNGX) with a Overweight rating and a...

 medivirs-licensee-tango-therapeutics-dosed-the-first-patient-with-tng348-a-novel-usp1-inhibitor

Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas o...

 b-riley-securities-initiates-coverage-on-tango-therapeutics-with-buy-rating-announces-price-target-of-16

B. Riley Securities analyst Yuan Zhi initiates coverage on Tango Therapeutics (NASDAQ:TNGX) with a Buy rating and announces ...

 tango-therapeutics-q3-eps-023-beats-034-estimate-sales-1073m-beat-732m-estimate

Tango Therapeutics (NASDAQ:TNGX) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(...

 wyndham-hotels--resorts-olink-holding-and-other-big-stocks-moving-higher-on-tuesday

U.S. stocks traded lower, with the Dow Jones falling around 50 points on Tuesday. Here are some big stocks recording gains in t...

 why-streamline-health-solutions-shares-are-trading-lower-by-over-68-here-are-other-stocks-moving-in-mondays-mid-day-session

Gainers MingZhu Logistics Holdings Limited (NASDAQ: YGMZ) shares gained 64% to $0.7798 after gaining more than 10% on Friday.

 why-belden-shares-are-trading-lower-by-over-25-here-are-other-stocks-moving-in-fridays-mid-day-session

Gainers Sigma Additive Solutions, Inc. (NASDAQ: SASI) shares jumped 196% to $7.34 after the company announced the signing o...

 why-inmode-shares-are-trading-lower-by-20-here-are-other-stocks-moving-in-thursdays-mid-day-session

Gainers

 why-parazero-technologies-shares-are-trading-higher-by-over-100-here-are-other-stocks-moving-in-mondays-mid-day-session

Gainers ParaZero Technologies Ltd. (NASDAQ: PRZO) shares jumped 106% to $2.3901 after the company announced an Australian re...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION